These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ticagrelor versus clopidogrel in acute coronary syndromes. Tomoda H N Engl J Med; 2009 Dec; 361(24):2385; author reply 2387-8. PubMed ID: 20007565 [No Abstract] [Full Text] [Related]
3. Ticagrelor versus clopidogrel in acute coronary syndromes. Wartak SA; Lotfi A; Rothberg M N Engl J Med; 2009 Dec; 361(24):2386-7; author reply 2387-8. PubMed ID: 20050198 [No Abstract] [Full Text] [Related]
4. Ticagrelor versus clopidogrel in acute coronary syndromes. Cattaneo M N Engl J Med; 2009 Dec; 361(24):2386; author reply 2387-8. PubMed ID: 20050197 [No Abstract] [Full Text] [Related]
5. Current Antiplatelet Agents in Acute Coronary Syndrome. Sachdeva A J Assoc Physicians India; 2015 Jan; 63(1):75-6. PubMed ID: 26591137 [No Abstract] [Full Text] [Related]
6. [Ticagrelor versus clopidogrel in patients with acute coronary syndromes: results of the PLATO study]. Preobrazhenskiĭ DV Kardiologiia; 2010; 50(1):68. PubMed ID: 20144161 [No Abstract] [Full Text] [Related]
7. The power of more than one. Armstrong PW; Westerhout CM Circulation; 2013 Feb; 127(6):665-7. PubMed ID: 23401110 [No Abstract] [Full Text] [Related]
9. Is clopidogrel adequate in 2013? Wheatcroft S Cardiovasc J Afr; 2013 Mar; 24(2):45. PubMed ID: 23750347 [No Abstract] [Full Text] [Related]
10. Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties. De Servi S; Cavallini C; Leonardi S; Ferlini M Int J Cardiol; 2015 Feb; 181():443-5. PubMed ID: 25590784 [No Abstract] [Full Text] [Related]
11. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. James SK; Pieper KS; Cannon CP; Storey RF; Becker RC; Steg PG; Wallentin L; Harrington RA; Stroke; 2013 May; 44(5):1477-9. PubMed ID: 23572474 [No Abstract] [Full Text] [Related]
12. Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed? Schühlen H Eur Heart J; 2014 Aug; 35(31):2055-7. PubMed ID: 24950694 [No Abstract] [Full Text] [Related]
13. [Ticagrelor: a novel antiplatelet agent for patients with acute coronary syndrome]. Hinneburg I Med Monatsschr Pharm; 2011 Jul; 34(7):226-32. PubMed ID: 21809597 [TBL] [Abstract][Full Text] [Related]
14. Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes. Huber K; Lip GY Thromb Haemost; 2013 Jul; 110(1):11-3. PubMed ID: 23743615 [No Abstract] [Full Text] [Related]
15. Ticagrelor--is there need for a new player in the antiplatelet-therapy field? Schömig A N Engl J Med; 2009 Sep; 361(11):1108-11. PubMed ID: 19717845 [No Abstract] [Full Text] [Related]
16. Ticagrelor in ACS: redefining a new standard of care? Stone GW Lancet; 2010 Jan; 375(9711):263-5. PubMed ID: 20079529 [No Abstract] [Full Text] [Related]
17. Is it appropriate to compare the results from two clinical trials with one drug in common? Marrugat J; Vila J; Elosua R Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):151-3. PubMed ID: 24775396 [No Abstract] [Full Text] [Related]